Thomas Jenkins, MD
Ophthalmology · Richmond, VANPI 1114345634
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,912 of the $25,904 with a category attached, or 65.3%. Regeneron Healthcare Solutions, Inc. accounts for 64.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $9,701 and has fallen 61.2% since, to $3,762 in 2025. Among ophthalmology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 31 payments — averaging $835.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$17K
- Genentech USA, Inc.$7K
- Regeneron$806
- Alimera Sciences, Inc.$596
- AbbVie$196
- Alcon$136
- plus $329 from 5 others
What the payments were for
- Consulting fees$5,94023%
- Speaking & faculty fees$16,91265%
- Travel & lodging$1,5876%
- Food & beverage$1,4656%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $16,713 |
| Genentech USA, Inc. | 6 | $7,128 |
| Regeneron | 2 | $806 |
| Alimera Sciences, Inc. | 3 | $596 |
| AbbVie(2 entities) | 5 | $196 |
| Alcon | 1 | $136 |
| Sight Sciences, Inc. | 1 | $123 |
| Astellas Pharma US Inc | 1 | $90 |
| Carl Zeiss Meditec, Inc. | 1 | $60 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $35 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA HD$16,684
- Lucentis$7,091
- Iluvien$596
- Constellation$136
- OMNI$123
How this compares
$25,904 in reported general payments places this provider in the 95th percentile of 509 ophthalmology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 236 | $7,842 |
| Ofloxacin | 120 | $1,294 |
| Ketorolac Tromethamine | 68 | $1,143 |
| Brimonidine Tartrate | 11 | $773 |
| Atropine Sulfate | 12 | $403 |
| Latanoprost | 29 | $282 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 14 | $239 |
| Timolol Maleate | 12 | $84 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Richmond
- Ethnie JonesRichmond$2M
- Jessica RandolphRichmond$18K
- Nikisha RichardsRichmond$16K
- Tam DangRichmond$9K
- Byron LaddRichmond$7K
- Bryan SchwentRichmond$7K
- Rishi ParikhRichmond$6K
- Elizabeth Yeu-LinNorfolk$1.7M
- John SheppardNorfolk$1.1M
- Constance OkekeNorfolk$800K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.